Vecsei Zsófia

1.

Kanchan, K., Ergülen, E., Király, R., Simon-Vecsei, Z., Fuxreiter, M., Fésüs, L.: Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity.
Biochem. J. 455 (3), 261-272, 2013.

doi DEA

Journal metrics:

D1 Biochemistry

Q1 Cell Biology

Q1 Molecular Biology

2.

Tóth, B., Kissné Bogáti, R., Király, R., Simon-Vecsei, Z., Caja, S., Bartáné Tóth, B., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L., Korponay-Szabó, I.: Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2.
JPGN. 56 (Suppl_2), 200, 2013.

DEA

3.

Tóth, B., Kissné Bogáti, R., Király, R., Simon-Vecsei, Z., Caja, S., Bartáné Tóth, B., Nadalutti, C., Lindfors, K., Mäki, M., Fésüs, L., Korponay-Szabó, I.: Lipoma-preferred partner protein (LPP), a genetic marker for coeliac disease predisposition is interacting with transglutaminase 2: 46th Annual Meeting of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN).

DEA

4.

Simon-Vecsei, Z., Király, R., Bagossi, P., Tóth, B., Dahlbom, I., Caja, S., Csősz, É., Lindfors, K., Sblattero, D., Nemes, É., Mäki, M., Fésüs, L., Korponay-Szabó, I.: A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
PNAS USA 109 (2), 431-436, 2012.

doi DEA

Journal metrics:

D1 Multidisciplinary

5.

Korponay-Szabó, I., Simon-Vecsei, Z., De Leo, L., Not, T.: Gluten-dependent Intestinal Autoimmune Response.
Curr. Pharm. Design. 18 (35), 5753-5758, 2012.

doi DEA

Journal metrics:

Q1 Drug Discovery

Q1 Pharmacology

6.

Korponay-Szabó, I., Fésüs, L., Csősz, É., Király, R., Simon-Vecsei, Z., Mäki, M., Bagossi, P.: Diagnosis and treatment of gluten-induced autoimmune diseases.

DEA

7.

Korponay-Szabó, I., Fésüs, L., Bagossi, P., Bagossi, P., Csősz, É., Király, R., Simon-Vecsei, Z., Mäki, M.: Diagnosis of gluten-induced autoimmune diseases.

DEA

8.

Myrsky, E., Caja, S., Simon-Vecsei, Z., Korponay-Szabó, I., Nadalutti, C., Collighan, R., Mongeot, A., Griffin, M., Mäki, M., Kaukinen, K., Lindfors, K.: Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA.
Cell. Mol. Life Sci. 66 (20), 3375-3385, 2009.

doi DEA

Journal metrics:

Q1 Cell Biology

D1 Cellular and Molecular Neuroscience

Q1 Molecular Biology

D1 Molecular Medicine

D1 Pharmacology

9.

Király, R., Csősz, É., Kurtán, T., Antus, S., Szigeti, K., Simon-Vecsei, Z., Korponay-Szabó, I., Keresztessy, Z., Fésüs, L.: Functional significance of five noncanonical Ca2+-binding sites of human transglutaminase 2 characterized by site-directed mutagenesis.
FEBS J. 276 (23), 7083-7096, 2009.

doi DEA

Journal metrics:

Q1 Biochemistry

Q2 Cell Biology

Q2 Molecular Biology

10.

Korponay-Szabó, I., Simon-Vecsei, Z., Király, R., Dahlbom, I., Chirdo, F., Nemes, É., Fésüs, L., Mäki, M.: Deamidated Gliadin Peptides Form Epitopes That Transglutaminase Antibodies Recognize.
J. Pediatr. Gastroenterol. Nutr. 46 (3), 253-261, 2008.

doi DEA

Journal metrics:

Q1 Gastroenterology

Q1 Pediatrics, Perinatology and Child Health

11.

Király, R., Simon-Vecsei, Z., Deményi, T., Korponay-Szabó, I., Fésüs, L.: Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase: dependence on reaction environment and enzyme fitness.
J. Autoimmun. 26 (4), 278-287, 2006.

doi DEA

Journal metrics:

Q2 Immunology

Q2 Immunology and Allergy

12.

Király, R., Simon-Vecsei, Z., Deményi, T., Korponay-Szabó, I., Fésüs, L.: Coeliac autoantibodies can enhance transamidating and inhibit GTPase activity of tissue transglutaminase.
FEBS J. 272 (Suppl1), 411, 2005.

doi DEA

Vecsei Zsófia

Publication list